Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global gamma-aminobutyric acid (CAS 56-12-2) market is anticipated to grow at a CAGR of 6.1% by 2023, according to a new report published by Gen Consulting Company. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).
The Global Market for gamma-aminobutyric acid (CAS 56-12-2) to 2023 offers detailed coverage of gamma-aminobutyric acid industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading gamma-aminobutyric acid producers to provide exhaustive coverage of the gamma-aminobutyric acid.
Report contents include
- Analysis of the gamma-aminobutyric acid market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on gamma-aminobutyric acid including products, sales/revenues, and market position
- Market structure, market drivers and restraints.
Key Regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America
Key Vendors
- Pharma Foods International Co., Ltd.
- Sekisui Chemical Co., Ltd.
- Zhejiang Yiwan Biolabs Co., Ltd.
- Shanghai Richen Nutritional Co., Ltd.
- Guangdong Luckerkong Biotech Co., Ltd.
- Tianjin Shijitianlong Biotechnology Co., Ltd.
- Ningxiang Jiayuan Biology Technology Co., Ltd.
- request free sample to get a complete list of companies